Celldex Therapeutics, Inc. (CLDX)
29.73
+1.17
(+4.10%)
USD |
NASDAQ |
Jun 09, 16:00
29.73
0.00 (0.00%)
After-Hours: 16:43
Celldex Therapeutics EPS Diluted (Quarterly) : -1.182 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -0.7591 |
| Kura Oncology, Inc. | -0.8276 |
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -78.68M |
| Revenue (Quarterly) | 0.015M |
| Total Expenses (Quarterly) | 78.70M |
| Enterprise Value | 1.456B |
| Gross Profit Margin (Quarterly) | -5.59K% |
| Profit Margin (Quarterly) | -524.6K% |
| Earnings Yield | -14.35% |
| Normalized Earnings Yield | -14.35 |